Tag Archives: PARP inhibitor

Evidence to the Efficacy of Iniparib, a PARP-1 Inhibitor, in BRCA2-associated Pancreatic Cancer

Fogelman DR, Wolff RA, Kopetz S, Javle M, Bradley C, Mok I, Cabanillas F, Abbruzzese JL. “ANTICANCER Investigation APR 2011″ Pancreatic cancer is surely an intense, frequently fatal malignancy that strikes 37,000 patients annually in the U.S.A. It’s badly responsive … Continue reading

Posted in Uncategorized | Tagged | Leave a comment